Unassociated Document
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

 
Date of Report (Date of earliest event reported) March 26, 2009

MEDIFAST, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
  
000-23016
  
13-3714405
(State or other jurisdiction of incorporation or organization)
  
(Commission File Number)
  
(IRS Employer Ident. No.)
         
11445 Cronhill Drive, Owing Mills, Maryland
  
21117
(Address of principal executive offices)
  
(Zip Code)
 
Registrant's telephone number, including area code (410)-581-8042


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
[  ]   Written communications pursuant to Rule 425 under the Securities Act (17 CFR    230.425)

[  ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR   240.14d-2(b))

[  ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 8.01 Other Events

The Board of Directors of the Registrant has authorized the repurchase of up to 500,000 shares of the Registrant's common stock and that pursuant to that authority the Registrant purchased 25,000 shares of its common stock on March 26, 2009 at an average price of $4.09 per share, aggregating $102,206. The stock repurchase program may be limited or terminated at any time without prior notice.

Stock repurchases under this program may be made through open market and privately negotiated transactions at times and in such amounts as management deems appropriate. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements and other market conditions.
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
    MEDIFAST, INC.  
Dated:  March 30, 2009      
       
 
 
 /s/ Michael S. McDevitt  
    Michael S. McDevitt  
    Chief Executive Officer